1-4 of 4
Derek Blair
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tafasitamab in Combination with a CD20xCD3 Bispecific T-Cell Engager Significantly Prolongs Survival in Preclinical Lymphoma Models

Eveline Schaadt, Christina Heitmüller, Solveig Peters, Kristina Ilieva, Derek Blair, Christiane Huth, Dominik Bartel, Sandra Zapf, Markus Eberl, Doris Mangelberger-Eberl, Frank Giles, Carsten Corvey
Journal: Blood
Blood (2023) 142 (Supplement 1): 2813.
https://doi.org/10.1182/blood-2023-188574
Published: 2023
Journal Articles

First-Mind: Final Analysis from a Phase Ib, Open-Label, Randomized Study to Assess Safety of Tafasitamab or Tafasitamab + Lenalidomide in Addition to R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

Grzegorz S. Nowakowski, Johannes Duell, Katerina Kopeckova, Marek Trneny, Christiane Pott, Mouhamad Khouja, John M. Burke, Maeve Waldron-Lynch, Steve Wagner, Amitava Mukhopadhyay, Derek Blair, David Belada
Journal: Blood
Blood (2022) 140 (Supplement 1): 3731–3733.
https://doi.org/10.1182/blood-2022-163160
Published: 2022
Journal Articles

Ultrasensitive MRD Profiling Predicts Outcomes in DLBCL after Frontline Therapy with Tafasitamab in Combination with Lenalidomide and R-CHOP

David M. Kurtz, Gregory J. Hogan, Andre Schultz, Katerina Kopeckova, Christian Kuffer, Derek Blair, Steve Wagner, Sandra Close, Maximilian Diehn, Jacob J. Chabon, Ash A. Alizadeh, Jason Westin
Journal: Blood
Blood (2022) 140 (Supplement 1): 3498–3499.
https://doi.org/10.1182/blood-2022-168378
Published: 2022
Journal Articles

Disease Kinetics Measured By Circulating Tumor DNA Correlates with Treatment Response after Tafasitamab in Combination with R-CHOP with or without Lenalidomide in First Line Treatment of DLBCL

Mouhamad Khouja, Anke Schilhabel, Michaela Kotrova, Monika Brüggemann, Christian Kuffer, Derek Blair, Nikos Darzentas, Christiane Pott
Journal: Blood
Blood (2021) 138 (Supplement 1): 3498.
https://doi.org/10.1182/blood-2021-153176
Published: 2021